2 research outputs found
Decoration of an α‑Resorcylate Nucleus as Part of the Manufacture of a Glucokinase Activator
The
need to define a set of processes for the manufacture of a
glucokinase activator called for an evaluation of different strategies
to differentiate the hydroxyls of an α-resorcylic acid derivative.
While direct functionalization proved possible, it did not allow access
to crystalline intermediates that offered control over the rejection
of process impurities. The strategy taken forward involved the installation
of a benzoyl protecting group using careful control of pH in order
to achieve useful levels of selectivity. This allowed the remaining
α-resorcylate hydroxyl to be functionalized using a Mitsunobu
reaction, with liquid–liquid partitioning being used to separate
downstream intermediates of interest away from the redox byproducts
of this reaction. Downstream challenges that were overcome in order
to deliver a commercially viable means of manufacturing the API included
developing an amidation reaction with a poorly reactive aminopyrazine
coupling partner
The Development of a Dimroth Rearrangement Route to AZD8931
Recently, the aminoquinazoline motif
has been highly prevalent
in anticancer pharmaceutical compounds. Synthetic methods are required
to make this structure on a multikilo scale and in high purity. The
initial route to aminoquinazoline AZD8931 suffered from the formation
of late-stage impurities. To avoid these impurities, a new high-yielding
Dimroth rearrangement approach to the aminoquinazoline core of AZD8931
was developed. Assessment of route options on a gram scale demonstrated
that the Dimroth rearrangement is a viable approach. The processes
were then evolved for large-scale production with learning from a
kilo campaign and two plant-scale manufactures. Identification of
key process impurities offers an insight into the mechanisms of the
Dimroth rearrangement as well as the hydrogenation of a key intermediate.
The final processes were operated on a 30 kg scale delivering the
target AZD8931 in 41% overall yield